Equillium Inc
NASDAQ:EQ

Watchlist Manager
Equillium Inc Logo
Equillium Inc
NASDAQ:EQ
Watchlist
Price: 0.7549 USD -3.22% Market Closed
Market Cap: 26.7m USD

P/OCF
Price to OCF

-1.3
Current
-1.7
Median
19.8
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-1.3
=
Market Cap
26.7m USD
/
Operating Cash Flow
-21.4m USD
Market Cap P/OCF
US
Equillium Inc
NASDAQ:EQ
26.7m USD -1.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -229 118.7
US
Abbvie Inc
NYSE:ABBV
379.4B USD 20.2
US
Amgen Inc
NASDAQ:AMGN
170.2B USD 14.8
US
Gilead Sciences Inc
NASDAQ:GILD
140B USD 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
132.4B USD -268.6
US
Epizyme Inc
F:EPE
94.1B EUR -491
AU
CSL Ltd
ASX:CSL
120B AUD 25.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.4B USD 16.8
US
Seagen Inc
F:SGT
39.3B EUR -79.3
NL
argenx SE
XBRU:ARGX
32.9B EUR -138.1
 
US
Equillium Inc
NASDAQ:EQ
Average P/OCF: 18.1
Negative Multiple: -1.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -229 118.7
US
Abbvie Inc
NYSE:ABBV
20.2
US
Amgen Inc
NASDAQ:AMGN
14.8
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -268.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -491
AU
CSL Ltd
ASX:CSL
25.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -79.3
NL
argenx SE
XBRU:ARGX
Negative Multiple: -138.1

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A